Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis

Effective drug development to combat metastatic disease in breast cancer would be aided by the availability of well-characterized preclinical animal models that (a) metastasize with high efficiency, (b) metastasize in a reasonable time-frame, (c) have an intact immune system, and (d) capture some of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuan, Yang, Howard H., Hu, Ying, Watson, Peter H., Liu, Huaitian, Geiger, Thomas R., Anver, Miriam R., Haines, Diana C., Martin, Philip, Green, Jeffrey E., Lee, Maxwell P., Hunter, Kent W., Wakefield, Lalage M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458155/
https://www.ncbi.nlm.nih.gov/pubmed/28430642
http://dx.doi.org/10.18632/oncotarget.15695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458155/
https://www.ncbi.nlm.nih.gov/pubmed/28430642
http://dx.doi.org/10.18632/oncotarget.15695

Ejemplares similares